Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis.
Most of the studies on 60-kDa and 10-kDa chlamydial heat shock proteins (HSPs) to date have been carried out with blood lymphocytes or serum antibody responses, which do not provide a clear picture of the actual pathogenesis as they do not differentiate primary infection from recurrent infection. Thus, in the present study induction of the immune response was evaluated by studying lymphoproliferation of both cervical and peripheral lymphocytes to synthetic peptides of cHSP60, cHSP10 and major outer membrane protein (MOMP) antigen. In addition, cervical antibody prevalence to MOMP antigen, cHSP60 and cHSP10 and cytokine levels in cervical washes was also determined. Positive proliferative responses of cervical lymphocytes to cHSP10 peptide were significantly higher (P < 0.05) in women with recurrent infections and that to MOMP antigen were significantly higher in primary infection. On proliferation of PBMCs with the above antigens, no significant difference was observed between primary and recurrent infection. Prevalence of cervical IgG and IgA antibodies to Chlamydia trachomatis was significantly higher (P < 0.05) during primary infection than recurrent infections. In contrast, prevalence of IgG and IgA antibodies to cHSP10 and IgG antibodies to cHSP60 was higher during recurrent infections than primary infections. Interferon (IFN)-gamma levels were significantly higher in cervical washes of women with recurrent infection and correlated strongly with cHSP60 antibody titres. Our data thus suggest that mucosal responses are more appropriate in understanding the pathogenesis of chlamydial infection and IFN-gamma could be involved in the modulation of immune responses towards chlamydial infection directly, by causing acute inflammation, or indirectly through modulation of HSP expression.
Agrawal
T
T
Institute of Pathology, ICMR, Safdarjang Hospital Campus, New Delhi, India.
Vats
V
V
Salhan
S
S
Mittal
A
A
D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial / Q000276:immunology*; D049109:Cell Proliferation; D002478:Cells, Cultured; D002584:Cervix Uteri / Q000276:immunology; D018835:Chaperonin 10 / Q000276:immunology; D018834:Chaperonin 60 / Q000276:immunology; D002690:Chlamydia Infections / Q000276:immunology*; D002692:Chlamydia trachomatis / Q000276:immunology*; D005260:Female; D006360:Heat-Shock Proteins / Q000276:immunology*; D006801:Humans; D018928:Immunity, Mucosal / Q000276:immunology; D007371:Interferon-gamma / Q000032:analysis; D053583:Interleukin-1beta / Q000032:analysis; D008213:Lymphocyte Activation / Q000276:immunology; D008875:Middle Aged; D018272:Porins / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D018835:Chaperonin 10; D018834:Chaperonin 60; D006360:Heat-Shock Proteins; D053583:Interleukin-1beta; D018272:Porins; C071677:omp1 protein, Chlamydia trachomatis; D007371:Interferon-gamma